Lineage Debt To Equity from 2010 to 2025

LCTX Stock  USD 0.63  0.03  5.00%   
Lineage Cell Debt To Equity yearly trend continues to be fairly stable with very little volatility. Debt To Equity is likely to outpace its year average in 2025. Debt To Equity is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. View All Fundamentals
 
Debt To Equity  
First Reported
2010-12-31
Previous Quarter
0.0419
Current Value
0.044
Quarterly Volatility
4.37775881
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lineage Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lineage Cell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 922.5 K, Interest Expense of 6 M or Total Revenue of 10.8 M, as well as many indicators such as Price To Sales Ratio of 22.99, Dividend Yield of 0.0015 or PTB Ratio of 2.8. Lineage financial statements analysis is a perfect complement when working with Lineage Cell Valuation or Volatility modules.
  
Check out the analysis of Lineage Cell Correlation against competitors.

Latest Lineage Cell's Debt To Equity Growth Pattern

Below is the plot of the Debt To Equity of Lineage Cell Therapeutics over the last few years. It is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. Lineage Cell's Debt To Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lineage Cell's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.04 %10 Years Trend
Slightly volatile
   Debt To Equity   
       Timeline  

Lineage Debt To Equity Regression Statistics

Arithmetic Mean(1.05)
Coefficient Of Variation(415.48)
Mean Deviation2.05
Median0.03
Standard Deviation4.38
Sample Variance19.16
Range17.6593
R-Value0.42
Mean Square Error16.90
R-Squared0.18
Significance0.10
Slope0.39
Total Sum of Squares287.47

Lineage Debt To Equity History

2025 0.044
2024 0.0419
2023 0.0465
2022 0.0531
2021 0.0304
2020 0.0343
2019 0.0458

About Lineage Cell Financial Statements

Lineage Cell investors use historical fundamental indicators, such as Lineage Cell's Debt To Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lineage Cell. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Debt To Equity 0.04  0.04 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lineage Stock Analysis

When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.